C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2004
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242892 5-(3-pyridylmethyl)imidazolidine-2,4-dione is subjected to a hydrolysis reaction, wherein the reaction is followed by a decarbamation reaction to obtain (3-pyridyl)alanine
12/02/2004	US20040242886 Induction apoptosis in tumor cells; antitumor, anticancer agents
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004	US20040242648 Compounds having simultaneous ability to block L-type calcium channels and to inhibit phosphodiesterase type 3 activity
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242615 enhancing the expression of apoAI; prevention or therapy of dislipidemia
12/02/2004	US20040242584 Muscarinic agonists
12/02/2004	US20040242581 potent inhibitors of factor Xa which may have high bioavailability following oral administration
12/02/2004	US20040242572 New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufacture
12/02/2004	US20040242494 Caspase inhibitors and uses thereof
12/02/2004	US20040242477 Capable of introducing aldehyde or ketone functions into proteins in a site-specific and pharmaceutically acceptable manner
12/02/2004	US20040242456 For controlling weeds, especially in crops of useful plants, or in inhibiting plant growth
12/02/2004	US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/01/2004	EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004	EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004	EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1480957A1 Hppars activators
12/01/2004	EP1480956A1 Halogen-free ionic liquids
12/01/2004	EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004	EP1480944A2 Substituted aryl ketones
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP1480934A2 Production of alkenones
12/01/2004	EP1357889A4 Novels couplers for use in oxidative hair dyeing
12/01/2004	EP1351991A4 Ternary biomolecule/polymer/surface-based immobilization systems
12/01/2004	EP1318996B1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
12/01/2004	EP1181280B1 Substituted benzoyl ketones, methods for producing them and their use as herbicides
12/01/2004	EP1073627B1 Processes for preparing pesticidal intermediates
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	EP0975586B1 Oxime compounds, their use, and intermediates for their production
12/01/2004	CN1551876A 6-aryl-4-aminopicolinates and their use as herbicides
12/01/2004	CN1551869A Novel compound
12/01/2004	CN1551761A Inhibitors of acyl glucosaminyl inositol amidase and methods of use
12/01/2004	CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177824C Hydroxy formamidine derivs. and medicines contg. same
12/01/2004	CN1177823C Pesticides
12/01/2004	CN1177822C Novel bipyridyl derivatives
12/01/2004	CN1177821C Matrix metalloprotease inhibitors
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825360 Bicyclic aromatic compounds
11/30/2004	US6825354 Osteoporosis; rheumatic diseases
11/30/2004	US6825235 Synthesis of taxol enhancers
11/30/2004	US6825221 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain
11/30/2004	US6825204 N-substituted 3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
11/30/2004	US6825189 Treating withdrawal symptoms caused by smoking cessation
11/30/2004	US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004	CA2362117C A system for cell-based screening
11/30/2004	CA2251795C Novel n-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
11/25/2004	WO2004101752A2 Compounds for treatment of inflammation, diabetes and related disorders
11/25/2004	WO2004101560A1 Processes for making thiazolidinedione derivatives and compounds thereof
11/25/2004	WO2004101524A1 Polyglycerol esters of pyridinecarboxylic acids
11/25/2004	WO2004101506A1 Glyoxalase inhibitors
11/25/2004	WO2004101505A1 Novel compounds for treatment of obesity
11/25/2004	WO2004100950A1 ‘(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004	WO2004087310A8 Ti-pillared clay based vandia catalyst and process for preparation
11/25/2004	WO2004085385A3 Cannabinoid receptor ligands
11/25/2004	WO2004084842A3 Inhibitors of cathepsin s
11/25/2004	WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004	WO2004067489A3 Hydroxyl compounds and compositions for cholesterol management and related uses
11/25/2004	WO2004050657A3 COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE
11/25/2004	WO2004043379A3 Chemical compounds
11/25/2004	WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040236084 2-Aminopyridine substituted heterocycles
11/25/2004	US20040235959 Insecticidal diamides
11/25/2004	US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004	US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004	US20040235909 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction
11/25/2004	US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004	US20040235905 preventing overload of Ca2+ ions in cells; ischemic heart diseases, ischemic cerebral diseases, ischemic renal diseases and in the protection of cells during thrombolytic therapy, angioplasty, bypass operation of coronary artery or organ transplantation and arrhythmias
11/25/2004	US20040235898 pyridinium salts such as 1-ethyl-(E,E)-2,6-bis[2-[4-(dimethylamino)phenyl]ethenyl]pyridinium chloride, used as fungicides, bactericides or insecticides on substrates
11/25/2004	US20040235888 Utilities of amide compounds
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235829 Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235823 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor
11/25/2004	US20040235084 biomimic cofactor; 3-substituted pyridium compounds; nicotinamides N-substituted with benzyl or polyoxyethylene glycol derivatives; bipyridyl rhodium hydride complex catalyst for reduction of the cofactor; polymer matrix; economical in large scale; biosensor or a chemical membrane bioreactor
11/25/2004	US20040234958 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040231558 Has a clear hue, high light fastness and high moisture resistance
11/25/2004	DE10320453A1 Neue Bioisostere von Actinonin New bioisosteres of Actinonin
11/25/2004	CA2525438A1 Glyoxalase inhibitors
11/25/2004	CA2525006A1 `(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/24/2004	EP1479666A1 Ester compound and medicinal use thereof
11/24/2004	EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004	EP1478625A1 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists
11/24/2004	EP1478620A1 Phenethanolamine derivatives for treatment of respiratory diseases
11/24/2004	EP1478364A2 Selective antibacterial agents
11/24/2004	EP1478358A1 Aryl ureas with angiogenesis inhibiting activity
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr

1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 633